Daily Cosmetic Research Analysis
Analyzed 15 papers and selected 3 impactful papers.
Summary
Three studies stand out today in cosmetic medicine: a large retrospective analysis indicates subcutaneous buttock augmentation can improve contour with low complication rates; a 620-patient machine learning model shows moderate ability to predict stem cell therapy outcomes in plastic surgery; and an animal toxicology study defines NOAELs for two common cosmetic preservatives, highlighting developmental risks.
Research Themes
- Cosmetic surgery safety and outcomes
- Predictive modeling for aesthetic treatment response
- Chemical safety of cosmetic preservatives
Selected Articles
1. Safety and Efficacy of Subcutaneous Buttock Augmentation in Indian Population: A Retrospective Analysis.
In 293 SSBA cases over seven years, no mortality and minimal complications were observed, with significant waist-to-hip ratio improvement in females. Technique emphasizes exclusive subcutaneous plane grafting using blunt cannulas, supporting a safer approach versus traditional methods linked to fat embolism.
Impact: Addresses a high-stakes safety issue in gluteal augmentation with a sizable cohort and pragmatic technique details, supporting safer practice adoption.
Clinical Implications: Prefer the subcutaneous plane with blunt cannulas and strict safety protocols for gluteal fat grafting to minimize severe complications; use cohort data to inform patient counseling and perioperative planning.
Key Findings
- Retrospective series of 293 SSBA patients (2017–2024) with no mortality and minimal complications.
- Mean graft volume: 557 mL (females) and 341.6 mL (males).
- Female waist-to-hip ratio improved from 0.81 to 0.72, indicating significant contour enhancement.
- Technique utilized ultrasound- and power-assisted liposuction with 5-mm blunt cannula grafting into the subcutaneous plane.
Methodological Strengths
- Relatively large single-center cohort spanning seven years.
- Clear procedural standardization emphasizing subcutaneous plane and blunt cannulas.
Limitations
- Retrospective, single-arm design without a control group.
- Follow-up duration and objective long-term outcomes not fully reported.
Future Directions: Prospective, controlled studies with standardized outcome measures and long-term surveillance; registry-based comparisons of subcutaneous vs. intramuscular techniques to quantify safety differentials.
BACKGROUND: Safe subcutaneous buttock augmentation (SSBA) offers a safer alternative to traditional gluteal fat grafting, addressing concerns of complications such as fat embolism. This study aims to establish the safety and efficacy of SSBA in an Indian cohort. MATERIALS AND METHODS: A retrospective analysis was conducted on 293 patients (287 females, 6 males) who underwent SSBA between January 2017 and September 2024. Fat was harvested using ultrasound-assisted liposuction and power-assisted liposuction, followed by grafting into the subcutaneous plane using a power-assisted device with a 5-mm blunt cannula. RESULTS: The mean fat grafting volume for females was 557 mL and 341.6 mL for males. There were no reported mortalities, and complications were minimal. For females, the mean waist-to-hip ratio improved significantly from 0.81 to 0.72 ( CONCLUSION: SSBA is a safe and effective procedure for buttock enhancement, showing significant improvement in body contour and minimal risk of complications. These results reinforce the importance of technique precision and safety protocol adherence.
2. A machine learning-based predictive model for stem cell therapy outcomes in plastic surgery.
Using 620 retrospective cases split into training and validation cohorts, the authors developed RF, SVM, and KNN models after logistic regression and LASSO-based feature selection, achieving moderate predictive performance for stem cell therapy outcomes. The work provides an initial data-driven framework to personalize aesthetic regenerative interventions.
Impact: Introduces and validates a multi-algorithm predictive pipeline for outcome stratification in plastic surgery stem cell therapy, addressing a major gap in patient selection.
Clinical Implications: Supports pre-treatment risk–benefit discussions and candidate stratification for stem cell therapies; guides data collection standards for future prospective validation.
Key Findings
- Retrospective cohort of 620 patients receiving stem cell therapy split 7:3 into training and validation sets.
- Feature selection via univariate analysis, multivariate logistic regression, and LASSO preceded model building.
- RF, SVM, and KNN models demonstrated moderate predictive accuracy in validation.
- Pipeline implemented with scikit-learn, enabling reproducible ML workflows.
Methodological Strengths
- Large sample size with internal validation cohort.
- Multistep feature selection reducing overfitting risk and improving interpretability.
Limitations
- Retrospective, single-setting data with no external validation.
- Only moderate performance; clinical utility requires threshold optimization and calibration.
Future Directions: Prospective multicenter external validation, inclusion of standardized outcome definitions, and exploration of model updating/transfer learning for broader generalizability.
OBJECTIVE: Stem cell therapy has emerged as a promising approach in plastic surgery, yet its efficacy varies markedly among individuals and lacks reliable predictive assessment tools. This study aimed to construct and validate a predictive model for assessing the therapeutic efficacy of stem cell therapy in plastic surgery by identifying key influencing factors through clinical data analysis and machine learning. METHODS: Patients who underwent stem cell therapy in the Department of Plastic Surgery from June 2021 to July 2024 were retrospectively included and randomly divided into a training set and a validation set at a 7:3 ratio. Baseline clinical data were collected, and independent influencing factors were screened via univariate analysis, followed by multivariate logistic regression and LASSO feature selection in the training set. Three machine learning models-random forest (RF), support vector machine (SVM), and K-nearest neighbors (KNN)-were constructed using Python 3.8.5 and the scikit-learn library, followed by performance validation in the validation set. RESULTS: A total of 620 patients who underwent stem cell therapy were included. In the training set ( CONCLUSION: The machine learning-based predictive model for stem cell therapy efficacy in plastic surgery, constructed through clinical data analysis, exhibits moderate predictive accuracy and may serve as a reference for clinical personalized treatment.
3. Effect of Isobutylparaben and Phenylmercuric Acetate on Juvenile Female Rats with Special Reference to Development, Neurobehavior, and Histopathology.
In juvenile female rats, 70-day gavage exposure to IBP or PMA produced dose-dependent developmental and neurobehavioral toxicity, hepatic/renal stress, and histopathological changes, with PMA being more toxic. NOAELs were established at 20 mg/kg/day (IBP) and 4 mg/kg/day (PMA), informing safety assessments for pediatric exposure.
Impact: Provides multi-endpoint subchronic NOAELs for two widely used cosmetic preservatives, directly informing regulatory toxicology and risk assessment.
Clinical Implications: Supports stricter evaluation of pediatric exposure to IBP and PMA-containing products, guiding labeling, formulation limits, and surveillance of neurodevelopmental endpoints.
Key Findings
- 70-day subchronic gavage exposure to IBP (10, 20, 50 mg/kg/day) and PMA (2, 4, 8 mg/kg/day) in juvenile female rats (n=10/group).
- High-dose exposure reduced terminal body weight, delayed vaginal opening, and impaired motor/exploratory behavior.
- Biochemical and histopathological evidence of hepatic and renal toxicity, including hepatocellular hypertrophy and tubular degeneration.
- PMA exhibited greater toxicity than IBP; NOAELs established at 20 mg/kg/day (IBP) and 4 mg/kg/day (PMA).
Methodological Strengths
- Subchronic 70-day exposure with multiple doses enabling dose–response assessment.
- Comprehensive multi-system endpoints (developmental, neurobehavioral, endocrine, histopathology).
Limitations
- Preclinical animal model limits direct extrapolation to humans.
- Only juvenile female rats assessed; sex- and species-specific effects remain uncertain.
Future Directions: Human biomonitoring and epidemiologic studies linking exposure levels to developmental outcomes; mechanistic studies on endocrine and neurodevelopmental pathways; assessment across sexes and life stages.
BACKGROUND/AIMS: Isobutylparaben (IBP) and phenylmercuric acetate (PMA) are extensively applied in pharmaceuticals, cosmetics, and industrial chemicals, and are of concern for developmental toxicity. This study was conducted to compare and assess the subchronic effects of IBP and PMA on growth, neurobehavior, reproduction, and organ integrity in juvenile female rats, and establish no-observed-adverse-effect levels (NOAELs). METHODS: Juvenile female Sprague-Dawley rats (n=10/group) were given IBP (10, 20, 50 mg/kg/day) or PMA (2, 4, 8 mg/kg/day) by gavage for 70 days. Assays encompassed growth assessment, onset of puberty (vaginal opening), estrous cyclicity (vaginal smears), neurobehavioral examination (open-field activity, sensory reflexes, grip strength, motor activity), haematology, serum biochemistry, thyroid hormones (ELISA), organ weights, and histopathology of reproductive, hepatic, and renal tissues. RESULTS: IBP and PMA at high doses significantly inhibited terminal body weight, postponed vaginal opening, disrupted motor function, and affected exploratory behavior. Biochemical indicators revealed hepatic and renal stress and histological findings of hepatocellular hypertrophy and renal tubular degeneration. PMA was somewhat more toxic. NOAELs were 20 mg/kg/day (IBP) and 4 mg/kg/day (PMA). CONCLUSION: Both IBP and PMA caused dose-dependent developmental toxicity, calling for more stringent pediatric exposure evaluations and chemical safety regulations.